Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits.
BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors One fund just walked away from BrightView — here’s what the numbers suggest long-term investors should really pay attention to.
Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year One fast-growing software company just won a major vote of confidence — here’s what’s behind it.
This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? One formerly high-flying alternative energy stock just got a surprising vote of confidence — here’s what the latest numbers reveal.
Whetstone Sells All Freshworks Shares The investment firm sold all of its shares in the AI firm.
OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout OptimizeRx (OPRX) stock shows a powerful breakout setup, combining a strong technical uptrend with explosive earnings and sales growth momentum.
OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance OptimizeRx Q3 earnings crush estimates with strong revenue and profit growth. The healthcare tech firm also raises its full-year 2025 guidance.
OPTIMIZERX CORP (NASDAQ:OPRX) Shows Strong Momentum with Minervini Trend Template and High Growth Fundamentals Discover how OptimizeRx (OPRX) exemplifies the Minervini Trend Template, combining strong technical momentum with explosive fundamental growth for a powerful stock setup.
UnitedHealth Group Under Siege: DOJ Probes and Cyberattack Aftermath Shake Healthcare Giant UnitedHealth Group (
NYSE: UNH ), a dominant force in the U.S. healthcare landscape, is currently embroiled in an unprecedented storm of regulatory and legal scrutiny. Federal Justice Department probes targeting its expansive vertical integration and Medicare Advantage billing practices are intensifying, while the company continues to reel from the catastrophic
OptimizeRx Corp (NASDAQ:OPRX) Combines Technical Strength with High-Growth Momentum OptimizeRx (OPRX) combines strong technical uptrend with explosive earnings growth, making it a top growth and momentum stock pick.
Top stock movements in today's session. Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
These stocks are moving in today's session Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Which stocks are moving before the opening bell on Friday? Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push OptimizeRx's stock jumped 22.66% after hours following strong Q2 earnings that beat expectations and lifted the share price from $12.84 to $15.75.
OptimizeRx Corp (NASDAQ:OPRX) Surges 15% After Blowout Q2 Earnings and Raised 2025 Guidance OptimizeRx Q2 2025 earnings crush estimates with $29.2M revenue (+55% YoY) and $0.24 EPS, sparking a 15% stock surge. Raised guidance signals strong growth ahead.
Curious about the stocks that are showing activity after the closing bell on Thursday? Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
